Coenzyme Q10 [Ubiquinone] Market Overview

Global Coenzyme Q10 (Ubiquinone) Market Size Was Valued at USD 676.85 Million in 2023, and is Projected to Reach USD 1635.58 Million by 2032, Growing at a CAGR of 10.3 % From 2024-2032.

Coenzyme Q10, also known as ubiquinone, is a vital compound found in every cell of the body. It plays a crucial role in producing energy for cell growth and maintenance. Additionally, Coenzyme Q10 acts as an antioxidant, protecting cells from damage caused by harmful molecules. It is particularly abundant in organs with high energy requirements such as the heart, liver, and kidneys. Coenzyme Q10 supplements are often used to support cardiovascular health and overall well-being.

The global CoQ10 market has been witnessing steady growth due to its increasing applications across various industries, including pharmaceuticals, cosmetics, and dietary supplements. In the pharmaceutical sector, CoQ10 is utilized in the treatment of various cardiovascular and neurodegenerative disorders, as well as in cancer therapy and periodontal diseases.

• In the cosmetics industry, CoQ10 is valued for its anti-aging properties, as it helps in reducing the appearance of wrinkles and fine lines, promoting skin firmness and elasticity. Additionally, it aids in protecting the skin from damage caused by environmental stressors and UV radiation. The dietary supplement sector is a significant contributor to the CoQ10 market, driven by growing consumer awareness regarding its potential health benefits, including its role in promoting heart health, enhancing energy levels, and boosting overall well-being.
• The market is also influenced by factors such as increasing healthcare expenditure, rising geriatric population, and expanding research and development activities aimed at exploring new applications of CoQ10. Overall, the Coenzyme Q10 market is expected to continue its growth trajectory in the coming years, driven by expanding applications across diverse industries and increasing consumer demand for health and wellness products.

Market Dynamics And Factors

Drivers:

Coenzyme Q10 is primarily used in pharmaceuticals, nutraceuticals, and the cosmetics industry. Coenzyme Q10 enjoys strong importance in the cosmetic industry, due to its antioxidant characteristics. It is the basic unit that is accountable for 95% of energy generation inside cells, and also acts as a decisive role in treating numerous diseases, such as CVD, secondary diabetes, lungs and kidney problems, and infertility. Therefore, the growing demand for coenzymes is expected to continue during the forecast period.

People who are conscious about health are making use of supplements in the form of capsules, pills, and powders. Coenzymes are basic supplements that are naturally created inside the body. When the level of coenzymes in Q10 declined, it creates significant problems. Therefore, it helps to increased utilization and is anticipated to have a high demand for coenzyme Q10 in the projected period.

Rising demand for healthy food by consumers is another factor that leads to the growth of the coenzyme Q10 market. People in America and Japan are aware of the intake of healthy foods, which will create a massive demand for products that contain coenzyme Q10 in the food market.

Furthermore, its application as a superior antioxidant has accelerated its adoption in various therapeutic applications that focus on reducing the occurrence of several metabolic disorders including diabetes, cancer, and cardiovascular disorders. Additionally, utilization of coenzyme Q10 supplements have encouraged positive outcomes, especially in patients on statin medications. This factor is expected to be the driving force for the growth of the global market for coenzyme Q10 during the future period.

Market Segmentation

Global Coenzyme Q10 [Ubiquinone] Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End-user/application segment analysis and Major key players analysis mentioned as below;

By Type, the Chemical Synthesis segment is expected to dominate the market during the forecast period

The Chemical Synthesis segment offers cost-effective production methods compared to other synthesis routes like fermentation or extraction from natural sources. This cost efficiency translates to competitive pricing for end products, driving higher demand. Secondly, chemical synthesis ensures consistent quality and purity, meeting regulatory standards more reliably than natural extraction methods. Additionally, advancements in chemical synthesis technologies have improved yield and scalability, enabling manufacturers to meet growing market demands efficiently. Moreover, chemical synthesis provides better control over the final product's characteristics, such as particle size and solubility, enhancing its suitability for various applications. Hence, these advantages position the Chemical Synthesis segment to dominate the global Coenzyme Q10 market, appealing to industries ranging from pharmaceuticals to cosmetics and dietary supplements.

By Application, the Cosmetics and Personal Care segment held the largest share of xx% in 2023

The Cosmetics and Personal Care segment is anticipated to wield significant influence over the global Coenzyme Q10 (Ubiquinone) market due to its diverse applications and increasing consumer demand for skincare and beauty products fortified with Coenzyme Q10. Coenzyme Q10, renowned for its antioxidant properties and ability to promote skin health, is increasingly incorporated into various cosmetics and personal care formulations, including creams, lotions, serums, and anti-aging products.

The increasing consumer awareness regarding the importance of skincare and the pursuit of youthful appearance drives the demand for Coenzyme Q10-infused products. Additionally, advancements in formulation technologies enable the efficient integration of Coenzyme Q10 into various cosmetic products, ensuring its stability and efficacy.

Furthermore, the growing trend of clean beauty and natural ingredients fosters the adoption of Coenzyme Q10, known for its natural occurrence in the human body. Overall, these factors position the Cosmetics and Personal Care segment as a primary driver of growth in the global Coenzyme Q10 market, with sustained dominance projected in the foreseeable future.

Regional Insights

North America region dominates coenzyme Q10 (Ubiquinone) market. In North America, there has been a growth in the utilization of coenzymes owing to high incidences of diseases, such as high blood pressure, high cholesterol (especially when taking statin drugs), coronary heart diseases, atherosclerosis, heart arrhythmia diseases, and congestive heart failures. Coenzymes help protect the heart and blood vessels from the damaging effects of oxidative stress. North America is probably to create prolific demand for the coenzyme Q10 (Ubiquinone) market over the forecast period.

Asia Pacific region has emerged as the fastest-growing market for coenzymes. Switching consumer lifestyles, coupled with rising health concerns in developing countries such as India and Japan are anticipated to drive segment growth. The development of small-scale producers along with growing cosmetics demand in India and China would be a positive sign for regional industry growth. Beneficial regulatory guidelines along with a positive application outlook in personal care industry demand would hasten the coenzyme Q10 (Ubiquinone) market demand.

In Europe, ~1 million people are influenced by Parkinson's disease, which has increased the economic burden associated with Parkinson's disease (PD) treatment in the region. According to the Spanish Healthcare System, the early stages of PD require costly treatment, which makes it difficult for middle-class people to bear the growing healthcare costs. Nevertheless, with arising consciousness regarding the benefits of coenzyme Q10, its demand for treating the disease is anticipated to rise among European countries, consequently helping the growth of the coenzyme Q10 market.

North Africa and countries in the Middle East are facing health problems similar to those in western countries. Of these health problems, CVD (cardiovascular diseases) is the high cause of death in these regions. The Middle East and Africa observed ~16% rise in cardiovascular disease rate in 2017. This is anticipated to grow the utilization of coenzyme Q10 in the region over the forecast period. Additionally, another factor helping the growth of the coenzyme Q10 market in the MEA region is the preference for anti-aging creams, according to a UN report.

Players Covered in Coenzyme Q10 [Ubiquinone] Market are:

• Spectrum Chemical Manufacturing Corp. (USA)
• Oriental Yeast Co., Ltd. (Japan)
• Sinoway Industrial Co., Ltd. (China)
• Kyowa Hakko Bio Co., Ltd. (Japan)
• Shandong Octagon Chemicals Limited (China)
• Xiamen Kingdomway Group Company (China)
• Shenzhou Biology & Technology Co., Ltd. (China)
• Kaneka Corporation (Japan)
• Hangzhou Jinlan Pharmaceutical Technology Development Co., Ltd. (China)
• Tokiwa Phytochemical Co., Ltd. (Japan)
• Kingdomway (China)
• Kaneka (Japan)
• NHU (China)
• Pharma Essentia (Taiwan)
• Yuxi Jiankun (China)
• Haotian (China)
• ZMC (China)

Key Industry Developments

• In November 2023, Kaneka Corporation, headquartered in Minato-ku, Tokyo, completed the acquisition of Japan Medical Device Technology Co., Ltd. (JMDT), located in Kamimashiki-gun, Kumamoto. As of the acquisition date, JMDT became a wholly-owned subsidiary of Kaneka. JMDT specializes in the development and manufacturing of medical devices, particularly renowned for its expertise in coronary stents, including bioresorbable varieties. Kaneka aims to leverage JMDT's technological prowess to expand its presence in the 30-billion-yen Japanese market for coronary artery disease treatments.
• In September 2022, Spectrum Chemical Mfg. Corp of Gardena, CA, solidifies its position as a key player in the biopharmaceutical industry with a new distribution agreement. Teaming up with DFE Pharma, a renowned global provider of pharma and nutraceutical solutions, Spectrum will now offer essential ingredients like BioHale® Sucrose and BioHale® Trehalose Dihydrate for biologics manufacturing, including COVID-19 vaccines. This expansion enhances Spectrum's comprehensive range of chemical ingredients for bioprocessing, ensuring a robust supply chain for critical pharmaceutical production needs.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. COENZYME Q10 (UBIQUINONE) MARKET BY TYPE (2017-2032)
   1. COENZYME Q10 (UBIQUINONE) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. CHEMICAL SYNTHESIS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. MICROBIAL FERMENTATION
7. COENZYME Q10 (UBIQUINONE) MARKET BY APPLICATION (2017-2032)
   1. COENZYME Q10 (UBIQUINONE) MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. DIETARY SUPPLEMENTS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. PHARMACEUTICALS
   5. COSMETICS
8. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. COENZYME Q10 (UBIQUINONE) Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. SPECTRUM CHEMICAL MANUFACTURING CORP. (USA)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. ORIENTAL YEAST CO., LTD. (JAPAN)
   4. SINOWAY INDUSTRIAL CO., LTD. (CHINA)
   5. KYOWA HAKKO BIO CO., LTD. (JAPAN)
   6. SHANDONG OCTAGON CHEMICALS LIMITED (CHINA)
   7. XIAMEN KINGDOMWAY GROUP COMPANY (CHINA)
   8. SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD. (CHINA)
   9. KANEKA CORPORATION (JAPAN)
   10. HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD. (CHINA)
   11. TOKIWA PHYTOCHEMICAL CO., LTD. (JAPAN)
   12. KINGDOMWAY (CHINA)
   13. KANEKA (JAPAN)
   14. NHU (CHINA)
   15. PHARMA ESSENTIA (TAIWAN)
   16. YUXI JIANKUN (CHINA)
   17. HAOTIAN (CHINA)
   18. ZMC (CHINA)
9. GLOBAL COENZYME Q10 (UBIQUINONE) MARKET BY REGION
   1. OVERVIEW
   2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Type
      4. Historic And Forecasted Market Size By Application
      5. Historic And Forecasted Market Size By Country
         1. USA
         2. Canada
         3. Mexico
   3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Russia
         2. Bulgaria
         3. The Czech Republic
         4. Hungary
         5. Poland
         6. Romania
         7. Rest Of Eastern Europe
   4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Germany
         2. United Kingdom
         3. France
         4. The Netherlands
         5. Italy
         6. Spain
         7. Rest Of Western Europe
   5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Malaysia
         6. Thailand
         7. Vietnam
         8. The Philippines
         9. Australia
         10. New-Zealand
         11. Rest Of APAC
   6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Turkey
         2. Bahrain
         3. Kuwait
         4. Saudi Arabia
         5. Qatar
         6. UAE
         7. Israel
         8. South Africa
   7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Brazil
         2. Argentina
         3. Rest of South America
10. INVESTMENT ANALYSIS
11. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. COENZYME Q10 [UBIQUINONE] MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. COENZYME Q10 [UBIQUINONE] MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. COENZYME Q10 [UBIQUINONE] MARKET COMPETITIVE RIVALRY
TABLE 005. COENZYME Q10 [UBIQUINONE] MARKET THREAT OF NEW ENTRANTS
TABLE 006. COENZYME Q10 [UBIQUINONE] MARKET THREAT OF SUBSTITUTES
TABLE 007. COENZYME Q10 [UBIQUINONE] MARKET BY TYPE
TABLE 008. CHEMICAL SYNTHESIS MARKET OVERVIEW (2016-2028)
TABLE 009. MICROBIAL FERMENTATION MARKET OVERVIEW (2016-2028)
TABLE 010. COENZYME Q10 [UBIQUINONE] MARKET BY APPLICATION
TABLE 011. FOOD MARKET OVERVIEW (2016-2028)
TABLE 012. MEDICINE MARKET OVERVIEW (2016-2028)
TABLE 013. COSMETICS MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 016. N COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 019. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 022. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 025. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET, BY APPLICATION (2016-2028)
TABLE 028. COENZYME Q10 [UBIQUINONE] MARKET, BY COUNTRY (2016-2028)
TABLE 029. KINGDOMWAY: SNAPSHOT
TABLE 030. KINGDOMWAY: BUSINESS PERFORMANCE
TABLE 031. KINGDOMWAY: PRODUCT PORTFOLIO
TABLE 032. KINGDOMWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. KANEKA: SNAPSHOT
TABLE 033. KANEKA: BUSINESS PERFORMANCE
TABLE 034. KANEKA: PRODUCT PORTFOLIO
TABLE 035. KANEKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. SPACE BIOLOGY: SNAPSHOT
TABLE 036. SPACE BIOLOGY: BUSINESS PERFORMANCE
TABLE 037. SPACE BIOLOGY: PRODUCT PORTFOLIO
TABLE 038. SPACE BIOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. NHU: SNAPSHOT
TABLE 039. NHU: BUSINESS PERFORMANCE
TABLE 040. NHU: PRODUCT PORTFOLIO
TABLE 041. NHU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. PHARMA ESSENTIA: SNAPSHOT
TABLE 042. PHARMA ESSENTIA: BUSINESS PERFORMANCE
TABLE 043. PHARMA ESSENTIA: PRODUCT PORTFOLIO
TABLE 044. PHARMA ESSENTIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. YUXI JIANKUN: SNAPSHOT
TABLE 045. YUXI JIANKUN: BUSINESS PERFORMANCE
TABLE 046. YUXI JIANKUN: PRODUCT PORTFOLIO
TABLE 047. YUXI JIANKUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. HAOTIAN: SNAPSHOT
TABLE 048. HAOTIAN: BUSINESS PERFORMANCE
TABLE 049. HAOTIAN: PRODUCT PORTFOLIO
TABLE 050. HAOTIAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. ZMC: SNAPSHOT
TABLE 051. ZMC: BUSINESS PERFORMANCE
TABLE 052. ZMC: PRODUCT PORTFOLIO
TABLE 053. ZMC: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY TYPE
FIGURE 012. CHEMICAL SYNTHESIS MARKET OVERVIEW (2016-2028)
FIGURE 013. MICROBIAL FERMENTATION MARKET OVERVIEW (2016-2028)
FIGURE 014. COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY APPLICATION
FIGURE 015. FOOD MARKET OVERVIEW (2016-2028)
FIGURE 016. MEDICINE MARKET OVERVIEW (2016-2028)
FIGURE 017. COSMETICS MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA COENZYME Q10 [UBIQUINONE] MARKET OVERVIEW BY COUNTRY (2016-2028)